Invesaro

Stocks Health care AIRS

NASDAQ · Health care

Airsculpt Technologies, Inc. (AIRS)

Airsculpt Technologies, Inc. brought in $147.7M of revenue over the twelve months to September 30, 2026, down 6.3% from a year earlier. It posted a net loss of $9.4M. Operating cash flow minus capital spending left $692K of free cash flow in fiscal 2025. At September 30, 2026 it held $15.2M in cash against $36.7M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 6, 2026.

Free, no password. An email when AIRS files with the SEC.

Price
$0.77
+14.11% on the day · November 10, 2026
52-week range $0.52 to $6.42
Market cap
$55.5M
Revenue (last 12 months)
$147.7M
-6.3% year on year
Net margin
-6.4%

Key facts about Airsculpt Technologies, Inc.

Net worth
Airsculpt Technologies, Inc. has a market value (market cap) of $55.5M at the latest share price, and shareholders' equity of $105.9M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $151.8M (-15.8% year on year), with a net loss of $11.7M. Over the 12 months to September 30, 2026: revenue $147.7M, net loss $9.4M.
Cash flow
In fiscal 2025 operations brought in $3.1M of cash; after $2.4M of capital spending, free cash flow was $692K.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 6, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
Next earnings report
Airsculpt Technologies, Inc.'s next report is expected around March 15, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

What Airsculpt Technologies, Inc. does

Airsculpt Technologies, Inc. is registered with the SEC under industry code SIC 8011 (Services-Offices & Clinics of Doctors of Medicine). Its shares trade on NASDAQ under the ticker AIRS.

Revenue and profit by year

Revenue
FY19: $41.2M $41.2M FY19FY21: $62.8M $62.8M FY21FY21: $133.3M $133.3M FY21FY22: $168.8M $168.8M FY22FY23: $195.9M $195.9M FY23FY24: $180.4M $180.4M FY24FY25: $151.8M $151.8M FY25
Net income
FY19: -$2.2M -$2.2M FY19FY21: $7.6M $7.6M FY21FY21: $10.6M $10.6M FY21FY22: -$14.7M -$14.7M FY22FY23: -$4.2M -$4.2M FY23FY24: -$8M -$8M FY24FY25: -$11.7M -$11.7M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$151.8M-$11.6M-$11.7M-$0.19$692K
2024$180.4M-$1.6M-$8M-$0.14-$2.7M
2023$195.9M$9.7M-$4.2M-$0.08$14M
2022$168.8M-$4.5M-$14.7M-$0.26$11.5M
2021$133.3M$15.8M$10.6M-$0.01$19.5M
2021$62.8M$10M$7.6Mn/a$10.3M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around March 15, 2027.

Estimated from its filing rhythm: 52 weeks after its report of March 16, 2026. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where AIRS ranks in Health care

Revenue$151.8M
#294 of 751 in Health care · Top 39%
Revenue growth-15.8%
#481 of 532 in Health care · Bottom 10%
Net margin-7.7%
#269 of 544 in Health care · Top 49%
Free cash flow margin0.5%
#235 of 490 in Health care · Top 48%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

Fiscal yearPer sharePaid outOf profit
2025n/a$0n/a
2024n/a$252Kn/a
2023n/a$385Kn/a
2022$0.41$23.2Mn/a
2021n/a$00%
2021n/a$00%

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What Airsculpt Technologies, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. November 6, 2026
    Quarterly report 10-Q · period to September 30, 2026Revenue fell 8.7% to $31.9M versus the same quarter last year; diluted EPS -$0.10 versus -$0.15.
  2. November 6, 2026
  3. November 6, 2026
  4. October 28, 2026
  5. August 12, 2026
  6. August 12, 2026
  7. August 10, 2026
  8. August 10, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue fell 2.5% to $42.9M versus the same quarter last year; diluted EPS -$0.02 versus -$0.01.
  9. August 10, 2026
  10. June 1, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on May 20, 2026. Insider transactions on SEC

What is AIRS worth? A DCF from its reported cash flow

Insider trades

What the people running Airsculpt Technologies, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
May 20, 2026 Feinstein Adam TDirector, 10% owner Other changeindirect 5,169,820 - - Form 4
May 12, 2026 Aaron Thomas JDirector Received as pay 100,286 - - Form 4
May 12, 2026 Chu CarolineDirector Received as pay 100,286 - - Form 4
May 12, 2026 Higgins KennethDirector Received as pay 100,286 - - Form 4
April 17, 2026 Chernett Jorey10% owner Bought 40,000 $2.54 $101.6K Form 4
April 14, 2026 Chernett Jorey10% owner Bought 20,000 $2.60 $52K Form 4
April 8, 2026 Arthur Michael JChief Financial Officer Received as pay 68,027 - - Form 4
April 8, 2026 Jashnani YogeshChief Executive Officer, Director Received as pay 238,095 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns AIRS

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Adam T Feinstein13G, passive with 4 related filers 42.1% 30,324,180 August 12, 2026
Rollins Aaron13G, passive 20.9% 14,721,062 June 1, 2026
Chernett Jorey13G, passive 10.79% 6,781,811 March 4, 2026
Parian Ultreia LP13G, passive 9.6% 6,744,000 April 21, 2026

Latest filings below 5%: Thrivent Financial For Lutherans 4.98% (October 28, 2026); SW Investment Management LLC 0% (February 13, 2026).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 103 managers reported a position.

HolderSharesValueChange on quarter
Vesey Street Capital Partners, L.L.C.30,324,180$136.5M0
BlackRock, Inc.1,278,871$5.8M+474,792
Wexford Capital LP841,734$3.8M+171,217
UBS Group AG792,183$3.6M+169,891
FourWorld Capital Management LLC750,000$3.4M-237,757
Flputnam Investment Management Co691,989$3.1Mnew
Aqr Capital Management LLC470,723$2.1M+161,394
Geode Capital Management, LLC451,224$2M+82,768
CenterBook Partners LP391,812$1.8Mnew
Millennium Management LLC373,324$1.7Mnew
State of Wisconsin Investment Board314,947$1.4M+26,947
Saba Capital Management, L.P.313,043$1.4M0
Jane Street Group, LLC299,702$1.3M+217,678
Citizens Financial Group Inc293,458$1.3M+27,597
Marshall Wace, Llp289,586$1.3M+213,530
Vanguard Capital Management LLC287,416$1.3M+53,784
State Street Corp277,693$1.2M+18,920
Goldman Sachs Group Inc238,215$1.1M+49,193
Tudor Investment Corp ET AL145,904$656.6K-130,775
Charles Schwab Investment Management Inc143,119$644K+38,167

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

8 insiders reported holding 15,440,234 shares in total, about $11.9M at the last price.

HolderSharesAs of
Chernett Jorey10% owner 7,053,761 April 17, 2026
Feinstein Adam TDirector, 10% owner 6,591,6426,591,642 held indirectly May 20, 2026
Jashnani YogeshChief Executive Officer, Director 696,475 April 8, 2026
Chu CarolineDirector 277,066 May 12, 2026
Aaron Thomas JDirector 276,866 May 12, 2026
Higgins KennethDirector 274,066 May 12, 2026
Arthur Michael JChief Financial Officer 215,086 April 8, 2026
Wadman Brent RGENERAL COUNSEL 55,272 April 8, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about AIRS

What does Airsculpt Technologies, Inc. do?

Airsculpt Technologies, Inc. is a company in the Health care sector, listed on NASDAQ as AIRS. Its shares trade on NASDAQ under the ticker AIRS.

What is Airsculpt Technologies, Inc.'s net worth?

Airsculpt Technologies, Inc. has a market value (market cap) of $55.5M at the latest share price, and shareholders' equity of $105.9M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Airsculpt Technologies, Inc. profitable?

No. Over the twelve months to September 30, 2026 it reported a net loss of $9.4M on revenue of $147.7M.

How much revenue does Airsculpt Technologies, Inc. make?

Over the twelve months to September 30, 2026 Airsculpt Technologies, Inc. reported revenue of $147.7M. That is 6.3% less than a year earlier.

When did Airsculpt Technologies, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on November 6, 2026. It covers the period to September 30, 2026.

When is Airsculpt Technologies, Inc.'s next earnings report?

Airsculpt Technologies, Inc.'s next report is expected around March 15, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare AIRS with

Compare AIRS with any company

Follow AIRS

Get an email when Airsculpt Technologies, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when AIRS files with the SEC.

Where the numbers come from

Financial figures are the values Airsculpt Technologies, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.